In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...
Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...
Speaking about obesity and diabetes, RFK Jr. said he would rather provide people with organic food three times a day than ...
Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...
President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...
A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...
Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
That includes the heart, lung, pancreas, digestive tract, arteries and veins, brain, kidney, and more “Equally important, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback